SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-016574
Filing Date
2024-03-29
Accepted
2024-03-29 15:26:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 ny20025434x1_s3.htm S-3 248453
2 EXHIBIT 5.1 ny20025434x1_ex5-1.htm EX-5.1 9504
3 EXHIBIT 23.1 ny20025434x1_ex23-1.htm EX-23.1 2008
4 EXHIBIT 107 ny20025434x1_ex107.htm EX-FILING FEES 11850
5 logo_elicio.jpg GRAPHIC 34211
6 ny20025434x1_ex5-1img01.jpg GRAPHIC 2596
  Complete submission text file 0001140361-24-016574.txt   323589
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278373 | Film No.: 24803923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)